Our proprietary technology creates a Temperature-Responsive Hydrogel
that remains liquid (Sol) at room temperature but turns into a gel(Gel)
at body temperature. A sustained-release technology characterized
by the direct injection of a drug mixture into the target site,
facilitating the gradual release of the therapeutic agent for 72 hours.